159 related articles for article (PubMed ID: 12604433)
1. Immune thrombocytopenia induced by fludarabine successfully treated with rituximab.
Fernandez MJ; Llopis I; Pastor E; Real E; Grau E
Haematologica; 2003 Feb; 88(2):ELT02. PubMed ID: 12604433
[No Abstract] [Full Text] [Related]
2. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
Telek B; Batár P; Uvardy M
Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine.
Tsutsumi Y; Kanamori H; Minami H; Musashi M; Fukushima A; Ehira N; Yamato H; Obara S; Ogura N; Tanaka J; Asaka M; Imamura M; Masauzi N
Ann Hematol; 2005 Apr; 84(4):269-71. PubMed ID: 15592832
[TBL] [Abstract][Full Text] [Related]
5. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Ahmadi T; Schuster SJ
J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
[No Abstract] [Full Text] [Related]
6. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
7. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Hegde UP; Wilson WH; White T; Cheson BD
Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
Usman M; Adil SN; Sajid R; Khurshid M
J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
[No Abstract] [Full Text] [Related]
10. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Bacchu S; Fegan C; Neal J
Br J Haematol; 2007 Nov; 139(3):349. PubMed ID: 17784883
[No Abstract] [Full Text] [Related]
11. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
[No Abstract] [Full Text] [Related]
12. Fludarabine for chronic lymphocytic leukemia.
Copur MS; Ledakis P; Muhvic J
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
[No Abstract] [Full Text] [Related]
13. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
Tam C; Seymour JF; Brown M; Campbell P; Scarlett J; Underhill C; Ritchie D; Bond R; Grigg AP
Haematologica; 2005 May; 90(5):700-2. PubMed ID: 15921393
[TBL] [Abstract][Full Text] [Related]
14. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
15. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
Sen K; Kalaycio M
Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
[No Abstract] [Full Text] [Related]
16. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
Hocepied AM; Falkson CI; Falkson G
S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
[No Abstract] [Full Text] [Related]
18. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
19. Fludarabine-induced eosinophilia: case report.
Voutsadakis IA
Ann Hematol; 2002 May; 81(5):292-3. PubMed ID: 12029541
[TBL] [Abstract][Full Text] [Related]
20. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
[Next] [New Search]